Diosgenin attenuates neuropathic pain in a rat model of chronic constriction injury

Zhao,Wei‑Xin; Wang,Peng‑Fei; Song,Hui‑Gang; Sun,Nai

doi:10.3892/mmr.2017.6723

Diosgenin attenuates neuropathic pain in a rat model of chronic constriction injury

Authors:
- Wei‑Xin Zhao
- Peng‑Fei Wang
- Hui‑Gang Song
- Nai Sun
View Affiliations

Affiliations: Department of Anesthesiology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, P.R. China
Published online on: June 8, 2017 https://doi.org/10.3892/mmr.2017.6723
Pages: 1559-1564

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diosgenin is a steroidal saponin extract from numerous plants, including Solanum and Dioscorea species, and has been reported to possess neuroprotective activity. However, the role of diosgenin in neuropathic pain remains unclear. The present study examined the effects of diosgenin on allodynia and the levels of inflammatory mediators in rats following neuropathic pain evoked by chronic constriction injury (CCI). In addition, the underlying molecular mechanisms involved in diosgenin‑induced suppression of neuropathic pain were examined. The results of the present study demonstrated diosgenin reversed CCI‑decreased mechanical withdrawal threshold and thermal withdrawal latency. Furthermore, diosgenin inhibited CCI‑induced upregulated levels of the pro‑inflammatory cytokines tumor necrosis factor‑α, interleukin (IL)‑1β and IL‑2, and suppressed oxidative stress induced by CCI in the spinal cord. Furthermore, diosgenin significantly inhibited the expression of phosphorylated‑p38 mitogen activated protein kinase (MAPK) and nuclear factor (NF)‑κB in the spinal cord in CCI rats compared with sham‑operated rats. In conclusion, the present study demonstrated that diosgenin attenuates neuropathic pain in CCI rats by inhibiting activation of the p38 MAPK and NF‑κB signaling pathways. These results implicate diosgenin in the treatment of neuropathic pain, which merits further clinical investigation.

View Figures

View References

1	Rowbotham MC: Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology. 65 12 Suppl 4:S66–S73. 2005. View Article : Google Scholar : PubMed/NCBI
2	Neville A, Peleg R, Singer Y, Sherf M and Shvartzman P: Chronic pain: A population-based study. Isr Med Assoc J. 10:676–680. 2008.PubMed/NCBI
3	Baastrup C and Finnerup NB: Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs. 22:455–475. 2008. View Article : Google Scholar : PubMed/NCBI
4	Finnerup NB, Otto M, McQuay H, Jensen TS and Sindrup SH: Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 118:289–305. 2005. View Article : Google Scholar : PubMed/NCBI
5	Dray A: Inflammatory mediators of pain. Brit J Anaesth. 75:125–131. 1995. View Article : Google Scholar : PubMed/NCBI
6	DeLeo JA and Yezierski RP: The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 90:1–6. 2001. View Article : Google Scholar : PubMed/NCBI
7	Kim HK, Park SK, Zhou JL, Taglialatela G, Chung K, Coggeshall RE and Chung JM: Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain. 111:116–124. 2004. View Article : Google Scholar : PubMed/NCBI
8	Ohtori S, Takahashi K, Moriya H and Myers RR: TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: Studies in murine DRG and spinal cord. Spine (Phila Pa 1976). 29:1082–1088. 2004. View Article : Google Scholar : PubMed/NCBI
9	Taves S, Berta T, Chen G and Ji RR: Microglia and spinal cord synaptic plasticity in persistent pain. Neural Plast. 2013:7536562013. View Article : Google Scholar : PubMed/NCBI
10	Ma W and Bisby MA: Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res. 797:243–254. 1998. View Article : Google Scholar : PubMed/NCBI
11	Jung DH, Park HJ, Byun HE, Park YM, Kim TW, Kim BO, Um SH and Pyo S: Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-kappaB and AP-1 activation. Int Immunopharmacol. 10:1047–1054. 2010. View Article : Google Scholar : PubMed/NCBI
12	Son IS, Kim JH, Sohn HY, Son KH, Kim JS and Kwon CS: Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem. 71:3063–3071. 2007. View Article : Google Scholar : PubMed/NCBI
13	Moalic S, Liagre B, Corbière C, Bianchi A, Dauça M, Bordji K and Beneytout JL: A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett. 506:225–230. 2001. View Article : Google Scholar : PubMed/NCBI
14	Tohda C, Urano T, Umezaki M, Nemere I and Kuboyama T: Diosgenin is an exogenous activator of 1, 25D3-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice. Sci Rep. 2:5352012. View Article : Google Scholar : PubMed/NCBI
15	Bennett GJ and Xie YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
16	Chaplan SR, Bach FW, Pogrel JM, Chung JM and Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
17	Hargreaves K, Dubner R, Brown F, Flores C and Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988. View Article : Google Scholar : PubMed/NCBI
18	Jaggi AS, Jain V and Singh N: Animal models of neuropathic pain. Fund Clin Pharmacol. 25:1–28. 2011. View Article : Google Scholar
19	Nadeau S, Filali M, Zhang J, Kerr BJ, Rivest S, Soulet D, Iwakura Y, de Rivero Vaccari JP, Keane RW and Lacroix S: Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1β and TNF: Implications for neuropathic pain. J Neurosci. 31:12533–12542. 2011. View Article : Google Scholar : PubMed/NCBI
20	Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG and Basso DM: Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol. 212:337–347. 2008. View Article : Google Scholar : PubMed/NCBI
21	Zhang JM and An J: Cytokines, inflammation, and pain. Int Anesthesiol Clin. 45:27–37. 2007. View Article : Google Scholar : PubMed/NCBI
22	Zanella JM, Burright EN, Hildebrand K, Hobot C, Cox M, Christoferson L and McKay WF: Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model. Spine (Phila Pa 1976). 33:227–234. 2008. View Article : Google Scholar : PubMed/NCBI
23	del Rey A, Yau HJ, Randolf A, Centeno MV, Wildmann J, Martina M, Besedovsky HO and Apkarian AV: Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts cytokine interactions in the hippocampus. Pain. 152:2827–2835. 2011. View Article : Google Scholar : PubMed/NCBI
24	Park ES, Gao X, Chung JM and Chung K: Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons. Neurosci Lett. 391:108–111. 2006. View Article : Google Scholar : PubMed/NCBI
25	Navarro SA, Serafim KG, Mizokami SS, Hohmann MS, Casagrande R and Verri WA Jr: Analgesic activity of piracetam: Effect on cytokine production and oxidative stress. Pharmacol Biochem Behav. 105:183–192. 2013. View Article : Google Scholar : PubMed/NCBI
26	Twining CM, Sloane EM, Milligan ED, Chacur M, Martin D, Poole S, Marsh H, Maier SF and Watkins LR: Peri-sciatic proinflammatory cytokines, reactive oxygen species and complement induce mirror-image neuropathic pain in rats. Pain. 110:299–309. 2004. View Article : Google Scholar : PubMed/NCBI
27	Ji RR and Suter MR: p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain. 3:332007. View Article : Google Scholar : PubMed/NCBI
28	Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J and Ji RR: Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun. 21:642–651. 2007. View Article : Google Scholar : PubMed/NCBI
29	Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL and Webb M: Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci. 22:2431–2440. 2005. View Article : Google Scholar : PubMed/NCBI
30	Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S and Inoue K: Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia. 45:89–95. 2004. View Article : Google Scholar : PubMed/NCBI
31	Sun T, Song WG, Fu ZJ, Liu ZH, Liu YM and Yao SL: Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Brit J Anaesth. 97:553–558. 2006. View Article : Google Scholar : PubMed/NCBI
32	Tegeder I, Niederberger E, Schmidt R, Kunz S, Gühring H, Ritzeler O, Michaelis M and Geisslinger G: Specific inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci. 24:1637–1645. 2004. View Article : Google Scholar : PubMed/NCBI
33	Lee KM, Jeon SM and Cho HJ: Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model. Eur J Pain. 13:794–806. 2009. View Article : Google Scholar : PubMed/NCBI
34	Wei XH, Yang T, Wu Q, Xin WJ, Wu JL, Wang YQ, Zang Y, Wang J, Li YY and Liu XG: Peri-sciatic administration of recombinant rat IL-1β induces mechanical allodynia by activation of src-family kinases in spinal microglia in rats. Exp Neurol. 234:389–397. 2012. View Article : Google Scholar : PubMed/NCBI